News
VRAX
2.370
+39.41%
0.670
Virax Biolabs Announces Strategic Goals and Developments for 2025
TipRanks · 1d ago
Virax Biolabs Announces 2025 Strategic Priorities, Highlighting Clinical Validation For Viraximmune And Global Expansion of ImmuneSelect
Benzinga · 1d ago
Weekly Report: what happened at VRAX last week (1209-1213)?
Weekly Report · 2d ago
BRIEF-Virax Biolabs Announces Agreement With Tebubio To Expand Distribution Of ImmuneSelect
Reuters · 12/10 14:25
Virax Biolabs Expands ImmuneSelect Reach in Europe
TipRanks · 12/10 12:58
Virax Biolabs enters non-exclusive distribution agreement with Tebubio
TipRanks · 12/10 12:35
Virax Biolabs Partners With Tebubio To Broaden Access To ImmuneSelect in the European Union, Norway, And Switzerland
Benzinga · 12/10 12:35
Weekly Report: what happened at VRAX last week (1202-1206)?
Weekly Report · 12/09 11:02
Weekly Report: what happened at VRAX last week (1125-1129)?
Weekly Report · 12/02 11:02
Weekly Report: what happened at VRAX last week (1118-1122)?
Weekly Report · 11/25 10:55
World Health Organization Says Mpox Continues To Constitute A Public Health Emergency Of International Concern
Benzinga · 11/22 17:43
Virax Biolabs Sees Asset Growth Amid Financial Loss
TipRanks · 11/20 21:29
Weekly Report: what happened at VRAX last week (1111-1115)?
Weekly Report · 11/18 10:52
Weekly Report: what happened at VRAX last week (1104-1108)?
Weekly Report · 11/11 11:04
Weekly Report: what happened at VRAX last week (1028-1101)?
Weekly Report · 11/04 11:02
Virax Biolabs Sets Date for 2024 AGM
TipRanks · 10/31 12:32
WHO Expands Emergency Use List For Mpox Diagnostics, Adds Cepheid's Xpert Mpox PCR Test And Roche's Cobas MPXV Assay As PCR-Based Gold Standard Options
Benzinga · 10/30 13:25
How Is The Market Feeling About Virax Biolabs Group?
Benzinga · 10/28 15:30
Weekly Report: what happened at VRAX last week (1021-1025)?
Weekly Report · 10/28 10:55
Nasdaq Down 2%; US Crude Stocks Increase
Benzinga · 10/23 18:30
More
Webull provides a variety of real-time VRAX stock news. You can receive the latest news about Virax Biolabs Group Ltd through multiple platforms. This information may help you make smarter investment decisions.
About VRAX
Virax Biolabs Group Limited is a biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. The Company is engaged in developing a T-Cell Test technologies with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against global viral threats. Its product portfolio includes ViraxClear and Virax Immune. ViraxClear offers a range of accurate diagnostic testing kits and machines. Virax Immune is a new Covid-19 test seeking detection of T-Cell immune responses to the SARS-Cov-2 virus. Its T-Cell testing is effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Monkeypox, Hepatitis B, Malaria, Herpes and Human Papillomavirus.